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OBJECTIVE—Leptin acts via its receptor (LepRb) to signal the
status of body energy stores. Leptin binding to LepRb initiates
signaling by activating the associated Janus kinase 2 (Jak2)
tyrosine kinase, which promotes the phosphorylation of tyrosine
residues on the intracellular tail of LepRb. Two previously
examined LepRb phosphorylation sites mediate several, but not
all, aspects of leptin action, leading us to hypothesize that Jak2
signaling might contribute to leptin action independently of
LepRb phosphorylation sites. We therefore determined the po-
tential role in leptin action for signals that are activated by Jak2
independently of LepRb phosphorylation (Jak2-autonomous
signals).
RESEARCH DESIGN AND METHODS—We inserted se-
quences encoding a truncated LepRb mutant (LepRb
65c, which
activates Jak2 normally, but is devoid of other LepRb intracellu-
lar sequences) into the mouse Lepr locus. We examined the
leptin-regulated physiology of the resulting / mice relative to
LepRb-deﬁcient db/db animals.
RESULTS—The / animals were similar to db/db animals in
terms of energy homeostasis, neuroendocrine and immune func-
tion, and regulation of the hypothalamic arcuate nucleus, but
demonstrated modest improvements in glucose homeostasis.
CONCLUSIONS—The ability of Jak2-autonomous LepRb sig-
nals to modulate glucose homeostasis in / animals suggests a
role for these signals in leptin action. Because Jak2-autono-
mous LepRb signals fail to mediate most leptin action, how-
ever, signals from other LepRb intracellular sequences pre-
dominate. Diabetes 59:782–790, 2010
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dipose tissue produces the hormone, leptin, in
proportion to fat stores to communicate the
status of long-term energy reserves to the brain
and other organ systems (1–4). In addition to
moderating food intake, adequate leptin levels permit the
expenditure of energy on myriad processes including
reproduction, growth, and immune responses, as well as
regulating nutrient partitioning (4–6). Conversely, lack of
leptin signaling due to null mutations of leptin (e.g.,
Lep
ob/ob mice) or the leptin receptor (LepR) (e.g., Lepr
db/db
mice) results in increased food intake in combination with
reduced energy expenditure (and thus obesity), neuroen-
docrine dysfunction (including hypothyroidism, decreased
growth, infertility), decreased immune function, and hy-
perglycemia and insulin insensitivity (1,7–9). Many of the
effects of leptin are attributable to effects in the central
nervous system, particularly in the hypothalamus, but
leptin also appears to act directly on some other tissues
(2,3).
Alternative splicing generates several integral-mem-
brane LepR isoforms that possess identical extracellular,
transmembrane, and membrane-proximal intracellular do-
mains. LepR intracellular domains diverge beyond the ﬁrst
29 intracellular amino acids, however, with the so-called
“short” isoforms (e.g., LepRa) containing an additional
3–10 amino acids, and the single “long” isoforms (LepRb)
containing a 300–amino acid intracellular tail (10). Like
other type I cytokine receptors (11), LepRb (which is
required for physiologic leptin action) contains no intrin-
sic enzymatic activity, but associates with and activates
the Janus kinase 2 (Jak2) tyrosine kinase to mediate leptin
signaling. The intracellular domain of LepRb possesses
membrane-proximal Box1 and Box2 motifs, both of which
are required for association with and regulation of Jak2;
although LepRa and other short LepRs contain Box1, they
lack Box2 and thus fail to bind and activate Jak2 under
physiologic conditions (12).
Leptin stimulation promotes the autophosphorylation
and activation of LepRb-associated Jak2, which phosphor-
ylates three LepRb tyrosine residues (Tyr985, Tyr1077, and
Tyr1138). Each LepRb tyrosine phosphorylation site re-
cruits speciﬁc Src homology 2 (SH2) domain–containing
effector proteins: Tyr985 recruits Src homology phospha-
tase-2 (SHP-2) and suppressor of cytokine signaling 3 and
attenuates LepRb signaling, but does not appear to play
other roles in leptin action in vivo (13–15). Tyr1077 recruits
the latent transcription factor, signal transducer, and
activator of transcription 5 (STAT5), and Tyr1138 recruits
STAT3 (16–18). Mice in which LepRb
S1138 (mutant for
Tyr1138 and thus speciﬁcally unable to recruit STAT3)
replaces endogenous LepRb exhibit hyperphagic obesity,
with decreased energy expenditure, but increased growth,
protection from diabetes, and preservation of several
aspects of hypothalamic physiology (19–21). These results
thus suggest roles for Tyr1077 and/or Jak2-dependent sig-
nals that are independent of LepRb tyrosine phosphoryla-
tion (“Jak2-autonomous signals”) in mediating Tyr985/
Tyr1138-independent leptin actions. Although others have
examined the effect of mutating all three LepRb tyrosine
phosphorylation sites in mice (22), revealing potential
tyrosine phosphorylation–independent roles for LepRb in
leptin action, that study did not examine several aspects of
leptin action and could not distinguish potential effects of
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LepRb/Jak2 interactions speciﬁcally.
RESEARCH DESIGN AND METHODS
Cell culture studies. The plasmids pcDNA3LepRb
65 and pcDNA3LepRa
were generated by mutagenesis of pcDNA3LepRb (23) using the QuikChange
kit (Stratagene). The absence of adventitious mutations was conﬁrmed by
DNA sequencing for all plasmids. Cell culture, transfection, lysis, and immu-
noblotting were conducted as reported previously using Jak2(pY1007/8)
from Cell Signaling Technology and Jak2 from our own laboratory (24).
Leptin was the generous gift of Amylin Pharmaceuticals (La Jolla, CA).
Mouse model generation. The targeting vector encoding LepRb
65 was
generated by inserting a Stop codon (QuikChange kit) after the 65th intracel-
lular amino acid of LepRb in the 5 targeting arm in the pBluescript plasmid;
this modiﬁed 5-arm was subsequently subcloned into the previously de-
scribed pPNT-derived targeting vector that contained the 3 arm (19,25,26).
The resulting construct was linearized and transfected into murine embryonic
stem (ES) cells with selection of clones by the University of Michigan
Transgenic Animal Model Facility. Correctly targeted clones were identiﬁed
and conﬁrmed with real-time PCR and Southern blotting as performed
previously (15,21,26) and were injected into embryos for the generation of
chimeras and the establishment of germ-line Lepr
65/ (/) animals. /
animals were intercrossed to generate / and / mice for the determina-
tion of hypothalamic Lepr expression or were backcrossed onto the C57BL/6J
background (The Jackson Laboratory) for six generations prior to intercross-
ing to generate / and / animals for the collection of other data.
Experimental animals. C57BL/6J wild-type, Lep
ob/, and Lepr
db/ breeders
were purchased from The Jackson Laboratory. All other animals and progeny
from these purchased breeders were housed and bred in our colony and were
cared for and used according to guidelines approved by the University of
Michigan Committee on the Care and Use of Animals. After weaning, all mice
were maintained on 5011 LabDiet chow. Mice were given ad libitum access to
food and water unless otherwise noted. For body weight, food intake, glucose
monitoring, and estrous monitoring, animals were weaned at 4 weeks and
housed individually. Body weight and food intake were recorded weekly from
4 to 8 weeks. Whole venous blood from the tail vein was used to determine
blood glucose (Ascensia Elite glucometer) and to obtain serum, which was
frozen for later hormone measurement. A terminal bleed was also collected
at the time of killing. Commercial ELISA kits were used to determine
insulin (Crystal Chem), leptin (Crystal Chem), and C-peptide (Millipore)
concentrations.
In females, vaginal lavage was used to assess estrous cycling daily from 4
to 8 weeks. Animals intended for glucose tolerance tests, insulin tolerance
tests, and body composition were weaned at 4 weeks and group housed. Body
composition was determined using an NMR Minispec LF90II scanner (Bruker
Optics) in the University of Michigan Animal Phenotyping Core.
Analysis of hypothalamic RNA. Hypothalami were isolated from ad libitum–
fed mice and snap-frozen. Total RNA was isolated using Trizol RNA reagent
(Invitrogen) and converted to cDNA using SuperScript reverse transcriptase
(Invitrogen). For comparison of relative LepRb expression, total hypothalamic
cDNA was subjected to PCR with LepRb-speciﬁc primers and subjected to gel
electrophoresis (21). For determination of relative neuropeptide expression,
total hypothalamic cDNA was subjected to automated ﬂuorescent RT-PCR on
an ABI Prism 7700 Sequence Detection System (Applied Biosystems) (21).
Immunologic cell analysis. For counting total splenocytes and splenic
T-cells, splenic T-cells were magnetically separated from the spleen by
autoMACS (Miltenyi Biotech, Bergisch Gladbach, Germany) as previously
described and counted by ﬂow cytometry (27). For proliferation assays,
T-cells were separated using CD90 microbeads, and 2  10
5 of these were
incubated with 2  10
4 B6 bone marrow–derived dendritic cells for 48, 72, and
96 h. Cells were stimulated with soluble anti-CD3e (1 mg/ml). Incorporation of
3H-thymidine (1 Ci/well) by proliferating cells during the last 12 h of culture
was measured.
Immunohistochemical analysis of hypothalamic brain sections. /,
db/, and / were intercrossed with heterozygous Agrp
LacZ mice expressing
LacZ from the Agrp locus (28,29) before recrossing to the parent Lepr strain
to generate experimental animals. For immunohistochemical analysis, ad
libitum–fed animals remained with food in the cage until the time of death.
Perfusion and immunohistochemistry were performed as described (30).
RESULTS
LepRb
65 and gene targeting to generate Lepr
65. To
examine physiologic signals generated by LepRb-associ-
ated Jak2 in the absence of LepRb tyrosine phosphoryla-
tion sites and other LepRb motifs (Jak2-autonomous
signals), we used a COOH-terminal truncation mutant of
LepRb (LepRb
65) that contains all motifs required for
Jak2 association and regulation, but which is devoid of
other intracellular LepRb sequences (12). Because we
previously demonstrated the function of this mutant intra-
cellular domain in the context of an erythropoietin recep-
tor (extracellular domain)/LepRb (intracellular domain)
chimera (12), we initially examined signaling by the trun-
cated intracellular domain within the context of LepRb
65
in transfected 293 cells (Fig. 1A). Leptin stimulation pro-
moted the phosphorylation of Jak2 on the activating
Tyr1007/1008 sites in LepRb
65- and LepRb-expressing cells
but not in LepRa-expressing or control cells (Fig. 1A),
conﬁrming that LepRb and LepRb
65, but not LepRa,
contain the necessary sequences to mediate Jak2 activa-
tion in response to leptin.
To understand the potential roles for Jak2-autonomous
LepRb signals in leptin action, we used homologous re-
combination to replace the genomic Lepr with Lepr
65
(henceforth referred to as the  allele, encoding LepRb
65)
in mouse ES cells (Fig. 1B). Correctly targeted ES cell
clones were conﬁrmed by Southern blotting (Fig. 1C). This
strategy mediates LepRb
65 expression from the native
Lepr locus, ensuring correct patterns and levels of
LepRb
65 expression, as previously for other homolo-
gously targeted LepRb alleles (15,21,26). Indeed, RT-PCR
analysis of hypothalamic mRNA conﬁrmed similar Lepr
mRNA expression in homozygous / animals and wild-
type animals (Fig. 1D). Prior to subsequent study, we
backcrossed heterozygous / animals to C57BL/6J mice
for six generations to facilitate direct comparison with
Lepr
db/db (db/db) animals on this background.
Energy homeostasis in / mice. Because our previous
analysis suggested some role for Tyr985/Tyr1138-indepen-
dent LepRb signals in regulating energy balance, we ini-
tially examined parameters of energy homeostasis in /
compared with db/db animals (15,19,21). We weaned and
singly housed /, db/db, and control mice from 4 to 8
weeks of age for the longitudinal determination of body
weight and food intake (Fig. 2A–D). Compared with age-
and sex-matched db/db animals, / mice displayed simi-
lar body weights and food intake over the study period.
Furthermore, age- and sex-matched / and db/db mice
displayed similar proportions of fat and lean mass (Table
1), revealing that / and db/db mice are similarly obese.
Core body temperature in / and db/db animals was also
similarly reduced compared with control animals (Table
1). Thus, LepRb
65 fails to alter major parameters of
energy homeostasis compared with entirely LepRb-deﬁ-
cient db/db mice, suggesting that Jak2-autonomous LepRb
signals are not sufﬁcient to modulate energy balance in
mice.
Linear growth and reproductive function in / mice.
In addition to modulating metabolic energy expenditure,
leptin action permits the use of resources on energy-
intensive neuroendocrine processes, such as growth and
reproduction. Whereas db/db and ob/ob animals that are
devoid of leptin action thus display decreased linear
growth and infertility, animals lacking Tyr985 or Tyr1138 of
LepRb display normal or enhanced linear growth and
preserved reproductive function, suggesting a role for
other LepRb signals in mediating these leptin actions
(15,19,21). Similar to db/db mice, / males displayed
decreased snout-anus length and femur length relative to
control animals (Table 1), however, suggesting the inabil-
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growth in the absence of other LepRb signals.
To determine the potential role for Jak2-autonomous
LepRb signals in the regulation of reproductive function,
we monitored estrous cycling from 4 to 8 weeks of age in
female mice, along with their ability to deliver pups after
housing with wild-type males. In addition to examining
/, db/db, and wild-type females in these assays, we
included mice homozygous for Lepr
tm1mgmj (a.k.a.,
Lepr
s1138 or s/s mice; mutant for Tyr11383STAT3 signal-
ing) (21) as a positive control for our ability to detect
residual reproductive function in obese mice with altered
leptin action (Table 2). Whereas essentially all wild-type
females and approximately half of the s/s females dis-
played vaginal estrus when housed in the absence of males
and delivered pups after cohabitation with male mice, /
females, like db/db animals, failed to undergo estrus or
deliver pups. Gross examination also revealed the repro-
ductive organs of / females were atrophic and similar to
those of db/db females (data not shown). Thus, Jak2-
autonomous LepRb signals are not sufﬁcient to mediate
leptin action on the reproductive axis.
Regulation of the hypothalamic ARC in / animals.
A number of aspects of leptin action in the hypothalamus
are beginning to be unraveled, including the role of leptin
in regulating arcuate nucleus (ARC) LepRb/proopiomela-
nocortin (POMC)-expressing neurons and their opposing
LepRb/agouti-related protein/neuropeptide Y (AgRP/NPY)-
expressing neurons (2,3,31,32). Leptin promotes anorectic
POMC expression, while inhibiting the expression of orexi-
genic AgRP and NPY and attenuating the activity of AgRP/
NPY neurons. Although LepRb Tyr11383STAT3 signaling is
required to promote Pomc mRNA expression, signals inde-
pendent of Tyr985 and Tyr1138 contribute to the suppression
of Agrp and Npy mRNA expression, and to the inhibition of
AgRP neuron activity (15,21,29). To determine the potential
role for Jak2-autonomous LepRb signals in the regulation of
these ARC neurons, we examined the mRNA expression of
Pomc, Npy, and Agrp in the hypothalamus and examined
c-fos immunoreactivity (c-fos-IR) as a surrogate for activity in
AgRP neurons (29) of male /, db/db, and wild-type mice
(Fig. 3). As expected based on the known role for Tyr1138 in
regulating Pomc, / and db/db mice exhibited signiﬁcantly
diminished Pomc mRNA expression compared with wild-
type controls (Fig. 3A); Pomc levels in / mice were lower
even than those in db/db mice. We found similarly elevated
Npy and Agrp mRNA expression in / and db/db mice
compared with wild-type mice (Fig. 3B and C).
To analyze c-fos-IR in AgRP neurons, we generated /,
/, and db/db animals heterozygous for Agrp
LacZ,i n
which -galactosidase (-gal) is expressed from the Agrp
locus, facilitating the detection of AgRP-expressing neu-
rons by -gal immunoﬂuorescence (29). Although fed
wild-type animals displayed c-fos-IR in few AgRP neurons,
a similarly large percentage of AgRP neurons in / and
db/db animals contained c-fos-IR, suggesting their activity
(Fig. 3D and E). Thus, Jak2-autonomous LepRb signals are
not sufﬁcient to mediate either the normal regulation of
ARC neuropeptide gene expression or the suppression of
c-fos-IR/activity in AgRP neurons.
Regulation of T-cell function by LepRb signals. Leptin
signals the status of energy stores to the immune system,
as well as to the brain systems that control energy balance
and neuroendocrine function. Leptin deﬁciency results in
thymic hypoplasia, reduced T-cell function, and conse-
quent immune suppression (6,33). Although we previously
FIG. 1. Generation of mice expressing LepRb
65. A: HEK293 cells were transfected with plasmids encoding the indicated LepR isoforms, made
quiescent overnight, incubated in the absence () or presence () of leptin (625 ng/ml) for 15 min before lysis, and immunoprecipitated with
Jak2 (24). Immunoprecipitated proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with the indicated
antibodies. The ﬁgures shown are typical of multiple independent experiments. B: Diagram of gene-targeting strategy to replace wild-type exon
18b with that encoding the COOH-terminally truncated LepRb
65. C: Southern blotting of control (wild-type) and correctly targeted (D/, C1, C2)
Lepr
65 ES lines, using a Lepr-speciﬁc probe. M indicates marker lane. D: Image of gel electrophoresis of Lepr-speciﬁc RT-PCR products from
hypothalamic mRNA of ﬁve wild-type and ﬁve / animals.
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for LepRb Tyr1138 signaling, suggesting improved immune
function in s/s compared with db/db mice (23), many other
parameters of immune function in these and other models
of altered LepRb signaling remain poorly understood. To
better understand the signaling mechanisms by which
LepRb modulates the immune system, we thus determined
the numbers of total and CD4
 splenocytes, as well as the
ex vivo proliferative capacity of splenic CD4
 cells from a
panel of mouse models of altered LepRb signaling. In
addition to examining wild-type, ob/ob, /, and s/s ani-
mals, we also studied mice homozygous for Lepr
tm2mgmj
(a.k.a., Lepr
l985 or l/l) mutant for LepRb Tyr985 (15) (Fig.
4). Note that ob/ob animals were used as the control for the
absence of leptin action in this study, as sufﬁcient numbers
of age-matched db/db animals were not available at the
time of assay. In addition to revealing the expected
decrease in total and CD4
 splenocytes and their prolifer-
ation in ob/ob animals relative to wild-type controls, we
found decreases in these parameters in / animals, and
normal parameters of immune function in s/s animals.
Interestingly, although l/l animals exhibit increased sensi-
tivity to the anorexic action of leptin (15), these parame-
ters of immune function actually trended down (albeit not
FIG. 2. Similar hyperphagia and obesity in / and db/db mice. Wild-type (f), db/db (E), and / (Œ) mice of the indicated age (n  8–10 per
genotype) were weaned at 4 weeks and body weight (A and B) and food intake (C and D) were monitored weekly from 4 to 8 weeks of age. Food
intake represents cumulative food intake over the time course. Data are plotted as means  SEM. *P < 0.05 compared with wild type (WT) by
one-way ANOVA and Tukey post-test.
TABLE 1
Phenotypic data for mice expressing mutant LepRb
Genotype Wild type db/db /
Fat content (%)
Male 6.0  0.7 (10) 47.0  1.1* (8) 47.8  0.9* (8)
Female 6.4  0.5 (8) 51.0  0.9* (8) 54.1  0.7* (11)
Lean content (%)
Male 80.0  0.4 (10) 43.7  1.1* (8) 42.6  0.8* (8)
Female 76.0  3.0 (8) 39.5  0.7* (8) 37.5  0.6* (10)
Body temperature (°C)
Male 34.6  0.2 (10) 33.0  0.2* (9) 33.4  0.2* (8)
Female 34.4  0.3 (8) 33.8  0.2 (9) 33.5  0.3 (12)
Snout-anus length (mm)
Male 88.5  0.8 (9) 82.6  2.7* (8) 83.0  1.0* (9)
Femur length (mm)
Male 13.9  0.1 (9) 11.8  0.1* (8) 12.0  0.1* (9)
Femur mass (mg)
Male 42.4  0.6 (9) 34.8  0.8* (8) 35.3  0.9* (9)
Fat and lean content were determined at 10 weeks and are expressed as a percentage of body weight. Body temperature was determined at
11 weeks. Snout-anus length, femur length, and femur weight were determined at 9 weeks. Data are means  SE; *P 	 0.05 compared with
wild type by Student unpaired, two-tailed t test. Sample size noted in parentheses.
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these data suggest that although Tyr985 and Tyr1138 are not
required for the promotion of splenic T-cell function by
leptin, Jak2-autonomous LepRb signals are not sufﬁcient
to mediate these aspects of leptin action.
Glucose homeostasis in / mice. Given the role for
leptin in modulating long-term glucose homeostasis
(2,20,34), we examined glycemic control in / mice.
Interestingly, we found that at 4 weeks of age, the blood
glucose levels in male and female / mice were normal,
whereas db/db mice were already signiﬁcantly diabetic
(Fig. 5A and B). At later time points, however, / animals
exhibited elevated blood glucose levels similar to those of
db/db mice. Similarly, male / mice displayed signiﬁ-
cantly lower fasting glucose levels than db/db mice at 6
weeks of age (Fig. 5C), and fasted females, although not
signiﬁcantly different from db/db animals, also tended to
have decreased blood glucose at this early age. Fasted
blood glucose in / animals of both sexes was elevated
and not signiﬁcantly different from db/db levels at older
ages, however (Fig. 5D). These data suggest that Jak2-
autonomous LepRb signals in / mice sufﬁce to delay the
onset of diabetes compared with db/db mice, but cannot
reverse the later progression to diabetes.
For female mice, there was no difference in serum
insulin levels between db/db and / mice at any age. In
male mice, insulin was also similar between db/db and /
mice at 4 weeks of age, but older / males displayed
increased circulating insulin levels compared with age-
matched db/db males. To discriminate potential alterations
in insulin clearance, we also examined serum C-peptide
levels, which mirrored insulin concentrations (supplemen-
tary Fig. 1, available in an online appendix at http://
diabetes.diabetesjournals.org/cgi/content/full/db09-
1556/DC1). These data suggest that the relative euglyce-
mia of / compared with db/db animals at 4 weeks of
age is not due to differences in insulin secretion (be-
cause insulin and C-peptide levels are similar between
genotypes, but / animals have decreased blood glu-
cose at this age), but must be secondary to modest
improvements in hepatic glucose output and/or insulin
sensitivity. This difference is transient, however, as the
increased insulin levels in older male / animals fail to
decrease blood glucose levels relative to those observed
in db/db animals. No difference in -cell mass was
detected between 12-week-old / and db/db mice (sup-
plementary Fig. 2).
In addition, we performed glucose and insulin toler-
ance tests in the / and db/db animals (supplementary
Fig. 3). Although 6-week-old female / animals dis-
played a diminished hyperglycemic response to the
glucose tolerance test relative to db/db controls, no
other differences between / and db/db mice were
observed. This suggests that the difference in glucose
homeostasis between / and db/db animals is small
and not sufﬁcient to reveal differences in the face of a
substantial glucose load and/or the increased insulin
resistance of advancing age.
TABLE 2
Fertility data for mice expressing mutant LepRb
Genotype Wild type db/db / s/s
Estrus 8/9 0/9 0/8 3/8
Litters 9/9 0/7 0/8 5/8
Individually housed females were examined daily from 4 to 8 weeks
of age. Cytologic examination of vaginal lavage was used to monitor
estrus. Females were paired with one wild-type male and monitored
daily for 6 weeks for the production of offspring.
FIG. 3. ARC neuropeptide expression and AgRP neuron c-fos-IR in wild-type (WT), db/db, and / mice. A–C: mRNA was prepared from the
hypothalami of 10- to 11-week-old male mice. Quantitative PCR was used to determine (A) Pomc,( B) Npy, and (C) Agrp mRNA levels (n  14–19
per genotype). D:c - fos-IR in AgRP neurons of ad libitum–fed wild-type, db/db, and / animals. All mouse groups were bred onto a background
expressing LacZ under the AgRP promoter, enabling the identiﬁcation of AgRP neurons by staining for -gal. Representative images showing
immunoﬂuorescent detection of c-fos (top), -gal (middle), and merged c-fos/-gal (bottom). E: Quantiﬁcation of double-labeled c-fos/AgRP-IR
neurons. Double-labeled AgRP neurons are plotted as percentage of total AgRP neurons  SEM. A–C and E:* P < 0.05 compared with wild type; †P <
0.05 compared with db/db by one-way ANOVA with Tukey post-test. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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To determine the potential roles for Jak2-autonomous
LepRb signals in leptin action in vivo, we generated a
mouse model in which LepRb is replaced by a truncation
mutant (LepRb
65) that contains within its intracellular
domain only the sequences required to associate with and
activate Jak2. We found that the hyperphagia, obesity,
linear growth, ARC physiology, and immune function of
these / mice closely resembled that of entirely LepRb-
deﬁcient db/db mice. / and db/db animals did demon-
strate some modest differences in glucose homeostasis;
however, both male and female / mice exhibited a
delayed progression to frank hyperglycemia compared
with db/db mice. Taken together, these ﬁndings demon-
strate that Jak2-autonomous LepRb signals may contribute
modestly to the modulation of glucose homeostasis by
leptin, but emphasize the necessity of signals emanating
from the COOH-terminus of LepRb (beyond the Jak2-
associating Box1 and Box2 motifs) for most leptin action.
The ﬁnding that 4-week-old / mice display similar
insulin and C-peptide levels as db/db animals, but exhibit
improved blood glucose levels, suggests improved glucose
disposal or decreased glucose production in the / mice
independent of insulin production. This is consistent with
data suggesting that central nervous system leptin action
suppresses hepatic glucose production, and with our pre-
vious ﬁnding that some portion of this is mediated inde-
pendently of Tyr11383STAT3 signaling (2,20,34). The /
mice progress rapidly (by 6 weeks of age) to dramatic
hyperglycemia and parameters of glucose homeostasis
indistinguishable from db/db animals, however. Indeed,
even at 5 weeks of age, the response to a glucose bolus is
comparably poor in male / and db/db animals and barely
improved in female / compared with db/db animals.
Furthermore, the increased insulin production of /
relative to db/db males at 6 weeks of age and beyond fails
to ameliorate their hyperglycemia. Thus, the improvement
in glucose homeostasis mediated by Jak2-autonomous
LepRb signals in / mice compared with db/db animals is
very modest, as it is easily overwhelmed by a large glucose
load and/or the increasing insulin resistance and diabetes
of advancing age. No difference in -cell mass was de-
tected between / and db/db males. The mechanism(s)
mediating the increased insulin production of the /
relative to db/db males is unclear, but could represent an
improvement in -cell function due to the later time at
which / animals become diabetic or to some residual
leptin action in the / -cell (35).
Although the overall similarity of ARC gene expression
and physiology between / and db/db mice indicates little
role for Jak2-autonomous LepRb signals in ARC leptin
action, the ﬁnding of decreased (worsened) Pomc mRNA
expression in / compared with db/db mice was surpris-
ing. One possible explanation for this observation is that
some residual signal mediated by LepRb
65 modestly
attenuates Pomc expression and that this attenuating
signal is overwhelmed under normal circumstances by the
LepRb signals that enhance Pomc expression. Unfortu-
nately, the low Pomc content of db/db and / animals and
low activity of these neurons at baseline rendered the
examination of POMC c-fos uninformative.
Although the molecular mechanisms underlying Jak2-
autonomous LepRb action remain unclear, several path-
ways could contribute. In cultured cells, the activation of
Jak2 by LepRb
65 and similar receptor mutants mediates
some activation of the extracellular signal–related kinase
pathway (13,36). Indeed, chemical inhibitor studies have
suggested a role for extracellular signal–related kinase
signaling in the regulation of autonomic nervous system
function by leptin, and the autonomic nervous system
underlies a major component of the leptin effect on
glucose homeostasis (37). Phosphatidylinositol 3-kinase
(PI 3-kinase) also plays a role in the regulation of glucose
homeostasis by leptin (38–41). As we have been unable to
observe the regulation of PI 3-kinase by leptin in cultured
cells and the analysis of this pathway in the hypothalami of
obese, hyperleptinemic mice remains problematic, the
molecular mechanism by which LepRb engages this path-
way remains unclear. Although difﬁcult to test directly, it is
thus possible that Jak2-autonomous LepRb signals might
modulate this pathway in vivo. We have previously dem-
onstrated that the major regulation of hypothalamic mam-
FIG. 4. Reduced numbers and proliferation of splenic T-cells in / and
ob/ob but not s/s or l/l mice. Spleens were isolated from the indicated
genotypes of male mice, separated using autoMACS, and counted for
(A) total splenocytes and (B) CD4
 cells using a ﬂow cytometer (n 
7–22 per genotype). Data are plotted as means  SEM; *P < 0.05
compared with wild type by one-way ANOVA and Tukey post-test. C:
For proliferation assays, CD4
CD25
 naive T-cells were isolated by
autoMACS (n  4–7 per genotype), incubated in the presence of bone
marrow–derived dendritic cells from C57BL/6J mice and stimulated
with anti-CD3e. Incorporation of H
3-thymidine (1 mCi/well) by prolif-
erating cells was measured during the last6ho fculture. Proliferation
is expressed as a percentage of a paired wild-type sample analyzed
concurrently (dashed line) and is plotted as mean  SEM; *P < 0.05 by
one-way ANOVA and Tukey post-test.
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to nutritional alteration, occurs indirectly, via neuronal
activation (42). We examined this pathway (along with the
phosphorylation of STAT3) in the hypothalamus of /
animals (supplementary Fig. 4), revealing the expected
absence of STAT3 signaling and increased mTOR activity
(secondary to the activation of orexigenic neurons) in the
mediobasal hypothalamus of db/db and / animals. Thus,
the regulation of mTOR is similar in these mouse models.
A potential intermediate linking Jak2 activation to PI
3-kinase activation is SH2B1, a SH2 domain–containing
protein that binds phosphorylated Tyr813 on Jak2 (43). Cell
culture studies show that SH2B1 binds directly to Jak2,
augments its kinase activity, and couples leptin stimula-
tion to insulin receptor substrate activation, a well-known
activator of PI 3-kinase (44). Indeed, SH2B1-null mice
display hyperphagia, obesity, and diabetes (45). SH2B1
could also mediate other, unknown Jak2-autonomous
LepRb signals.
Importantly, the phenotype of mice expressing LepRb
65
differs signiﬁcantly from a mouse model in which
LepRb
Y123F (mutated for the three tyrosine phosphoryla-
tion sites, but with an otherwise intact intracellular do-
main) replaces LepRb (22). Unlike / animals, these
Lepr
Y123F mice display improved energy homeostasis and
more dramatic improvements in glucose homeostasis
(both of which are sustained into adulthood), compared
with db/db animals. Unfortunately, the C57 genetic back-
ground strain used to study the Lepr
Y123F mice not only
differs compared with the C57BL/6J background that we
used to study our / and db/db animals, but also diverges
from that of the db/db animals used as comparators for the
Lepr
Y123F mice (22). Similarly, it is also possible that
minor differences between the incipient C57BL/6J back-
grounds of db/db and / mice could contribute to the
modest distinctions observed between these two models.
Aside from the background strain, the intriguing possi-
bility arises that the intracellular domain of LepRb may
mediate heretofore unsuspected signals independently
from tyrosine phosphorylation. As it is, future studies will
be needed to carefully compare the phenotype of
Lepr
Y123F, /, and db/db animals within the same facility
and on the same genetic background; should these differ-
ences remain, further work will be necessary to conﬁrm
the importance and determine the identity of the underly-
ing signaling.
FIG. 5. Delayed onset of hyperglycemia in / compared with db/db mice. A–D: Blood glucose was determined for ad libitum–fed (A and B)o r
fasted (5 h) (C and D) animals of the indicated genotype (wild type [WT], f; db/db, ; and /, Œ) and sex at the indicated ages (n  8–12 per
genotype). E and F: Serum was collected from mice of the indicated genotype and sex at the indicated ages (n  8–10 per genotype), and insulin
content was determined by ELISA. All panels: Data are plotted as means  SEM; *P < 0.05, db/db compared with / at the indicated time points
by one-way ANOVA and Tukey post-test.
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Jak2-autonomous LepRb signals for the bulk of leptin
action. These ﬁnding do not rule out the possibility that
Jak2-autonomous signals may be required to support the
action of LepRb phosphorylation, however. Indeed, our
present ﬁndings suggest a modest role for Jak2-autono-
mous LepRb signals in the regulation of glucose homeosta-
sis by leptin. Understanding collaborative roles for Jak2-
autonomous signals in leptin action and deciphering the
mechanisms underlying these signals and potential ty-
rosine phosphorylation–independent signals mediated by
the COOH-terminus of LepRb will represent important
directions for future research.
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